Research and clinical trials


The dermatology department plays an active role in research designed to improve the understanding and treatment of skin disease and help develop new treatments for patients.

If you are interested in being part of a clinical trial, then feel free to ask your dermatology doctor or nurse whether there is a trial that may be suitable for you.
All patients are also encouraged to register to take part in the Exeter 10,000 project.

More on what we do

Non-commercial studies:

BADBIR – UK Register of patients receiving biologic therapy for psoriasis
Alpha trial – comparing UV treatment to Alitretinoin tablets for severe hand dermatitis

Commercial studies:

The department is involved in a number of commercial research studies, comparing new or existing pharmaceutical drugs or interventions. These studies cover a range of skin conditions including psoriasis, actinic keratosis and skin lymphoma.


We have established collaborations with the University of Exeter, including the Centre for Biomedical Modelling and Analysis and with the Gastroenterology research team as part of their study on Skin reactions in patients on Anti-TNF medication for their Inflammatory Bowel disease.

Our team

Mr Robert James is the NIHR Dermatology Research nurse coordinating the delivery of both non-commercial and commercial studies and clinical trials in the dermatology department.

Dr Yusur Al-Nuaimi is the Research lead for the Dermatology department and the Peninsula Dermatology Speciality Lead for the National Institute for Health Research (NIHR) Dermatology Network. She and Dr Carolyn Charman are members of the UK Dermatology Clinical Trials Network Steering Group. These groups direct how dermatology research studies are conducted and delivered across the UK.

Where to find us

RD&E Heavitree, Gladstone Rd, Exeter EX1 2ED

Department of Dermatology

Contact us

If you want to get in touch with the department, please contact us on 01392 405510.


Our site uses cookies to help give you a better experience. By continuing to use it you consent to the use of cookies as set out in our privacy policy.